Terms: = Germ cell tumor AND FOXA1, TCF3A, 3169, ENSG00000129514, P55317, HNF3A, MGC33105
32 results:
1. Neuroprotective role of foxa1 in Parkinson's disease: Involvements of NF1 transcription activation and MAPK signaling pathway inhibition.
Fan Y; Zhao M; Hao F; Sun R; Chen J; Liu J
Brain Res Bull; 2024 Jan; 206():110860. PubMed ID: 38143008
[TBL] [Abstract] [Full Text] [Related]
2. Long non-coding RNA SOX2-OT enhances cancer biological traits via sponging to tumor suppressor miR-122-3p and miR-194-5p in non-small cell lung carcinoma.
Dodangeh F; Sadeghi Z; Maleki P; Raheb J
Sci Rep; 2023 Jul; 13(1):12371. PubMed ID: 37524903
[TBL] [Abstract] [Full Text] [Related]
3. LncRNA NKILA Exacerbates Alzheimer's Disease Progression by Regulating the foxa1-Mediated Transcription of TNFAIP1.
Zhou Y; Wang Y; Wang Y; Chen L; Wang N; Su Y; Diwu Y; Zhang Q
Neurochem Res; 2023 Sep; 48(9):2895-2910. PubMed ID: 37217807
[TBL] [Abstract] [Full Text] [Related]
4. Genes critical for development and differentiation of dopaminergic neurons are downregulated in Parkinson's disease.
Verma A; Kommaddi RP; Gnanabharathi B; Hirsch EC; Ravindranath V
J Neural Transm (Vienna); 2023 Apr; 130(4):495-512. PubMed ID: 36820885
[TBL] [Abstract] [Full Text] [Related]
5. FOXA2 drives lineage plasticity and KIT pathway activation in neuroendocrine prostate cancer.
Han M; Li F; Zhang Y; Dai P; He J; Li Y; Zhu Y; Zheng J; Huang H; Bai F; Gao D
Cancer Cell; 2022 Nov; 40(11):1306-1323.e8. PubMed ID: 36332622
[TBL] [Abstract] [Full Text] [Related]
6. Detection of disease-causing mutations in prostate cancer by NGS sequencing.
Mangolini A; Rocca C; Bassi C; Ippolito C; Negrini M; Dell'Atti L; Lanza G; Gafà R; Bianchi N; Pinton P; Aguiari G
Cell Biol Int; 2022 Jul; 46(7):1047-1061. PubMed ID: 35347810
[TBL] [Abstract] [Full Text] [Related]
7. Reprogramming of the foxa1 cistrome in treatment-emergent neuroendocrine prostate cancer.
Baca SC; Takeda DY; Seo JH; Hwang J; Ku SY; Arafeh R; Arnoff T; Agarwal S; Bell C; O'Connor E; Qiu X; Alaiwi SA; Corona RI; Fonseca MAS; Giambartolomei C; Cejas P; Lim K; He M; Sheahan A; Nassar A; Berchuck JE; Brown L; Nguyen HM; Coleman IM; Kaipainen A; De Sarkar N; Nelson PS; Morrissey C; Korthauer K; Pomerantz MM; Ellis L; Pasaniuc B; Lawrenson K; Kelly K; Zoubeidi A; Hahn WC; Beltran H; Long HW; Brown M; Corey E; Freedman ML
Nat Commun; 2021 Mar; 12(1):1979. PubMed ID: 33785741
[TBL] [Abstract] [Full Text] [Related]
8. Genome-Wide Analysis Unveils DNA Helicase RECQ1 as a Regulator of Estrogen Response Pathway in Breast Cancer cells.
Lu X; Redon CE; Tang W; Parvathaneni S; Bokhari B; Debnath S; Li XL; Muys BR; Song Y; Pongor LS; Sheikh O; Green AR; Madhusudan S; Lal A; Ambs S; Khan J; Aladjem MI; Sharma S
Mol Cell Biol; 2021 Mar; 41(4):. PubMed ID: 33468559
[TBL] [Abstract] [Full Text] [Related]
9. Post-transcriptional Gene Regulation by MicroRNA-194 Promotes Neuroendocrine Transdifferentiation in Prostate Cancer.
Fernandes RC; Toubia J; Townley S; Hanson AR; Dredge BK; Pillman KA; Bert AG; Winter JM; Iggo R; Das R; Obinata D; ; Sandhu S; Risbridger GP; Taylor RA; Lawrence MG; Butler LM; Zoubeidi A; Gregory PA; Tilley WD; Hickey TE; Goodall GJ; Selth LA
Cell Rep; 2021 Jan; 34(1):108585. PubMed ID: 33406413
[TBL] [Abstract] [Full Text] [Related]
10. The transcriptional factors CDX2 and foxa1 in chordomas.
Dridi M; Boutonnat J; Dumollard JM; Peoc'h M; Karpathiou G
Pathol Res Pract; 2020 Nov; 216(11):153160. PubMed ID: 32911347
[TBL] [Abstract] [Full Text] [Related]
11. Whole-genome sequencing of glioblastoma reveals enrichment of non-coding constraint mutations in known and novel genes.
Sakthikumar S; Roy A; Haseeb L; Pettersson ME; Sundström E; Marinescu VD; Lindblad-Toh K; Forsberg-Nilsson K
Genome Biol; 2020 Jun; 21(1):127. PubMed ID: 32513296
[TBL] [Abstract] [Full Text] [Related]
12. Signification of forkhead box A1 (foxa1) expression in thyroid cancers.
Missaoui N; Chouaibi S; Limam S; Mhamdi N; Zahmoul T; Hamchi H; Mokni M; Hmissa S
J Egypt Natl Canc Inst; 2019 Dec; 31(1):11. PubMed ID: 32372175
[TBL] [Abstract] [Full Text] [Related]
13. Long non-coding RNA LOC730100 enhances proliferation and invasion of glioma cells through competitively sponging miR-760 from foxa1 mRNA.
Li Q; Lu J; Xia J; Wen M; Wang C
Biochem Biophys Res Commun; 2019 May; 512(3):558-563. PubMed ID: 30914197
[TBL] [Abstract] [Full Text] [Related]
14. ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis.
Rotinen M; You S; Yang J; Coetzee SG; Reis-Sobreiro M; Huang WC; Huang F; Pan X; Yáñez A; Hazelett DJ; Chu CY; Steadman K; Morrissey CM; Nelson PS; Corey E; Chung LWK; Freedland SJ; Di Vizio D; Garraway IP; Murali R; Knudsen BS; Freeman MR
Nat Med; 2018 Dec; 24(12):1887-1898. PubMed ID: 30478421
[TBL] [Abstract] [Full Text] [Related]
15. Integrative functional genomics identifies regulatory genetic variant modulating RAB31 expression and altering susceptibility to breast cancer.
Zhang Y; Yang B; Cheng X; Liu L; Zhu Y; Gong Y; Yang Y; Tian J; Peng X; Zou D; Yang L; Mei S; Wang X; Lou J; Ke J; Li J; Gong J; Chang J; Yuan P; Zhong R
Mol Carcinog; 2018 Dec; 57(12):1845-1854. PubMed ID: 30182384
[TBL] [Abstract] [Full Text] [Related]
16. The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.
Ramnarine VR; Alshalalfa M; Mo F; Nabavi N; Erho N; Takhar M; Shukin R; Brahmbhatt S; Gawronski A; Kobelev M; Nouri M; Lin D; Tsai H; Lotan TL; Karnes RJ; Rubin MA; Zoubeidi A; Gleave ME; Sahinalp C; Wyatt AW; Volik SV; Beltran H; Davicioni E; Wang Y; Collins CC
Gigascience; 2018 Jun; 7(6):. PubMed ID: 29757368
[TBL] [Abstract] [Full Text] [Related]
17. Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast.
Lavigne M; Menet E; Tille JC; Lae M; Fuhrmann L; Bonneau C; Deniziaut G; Melaabi S; Ng CCK; Marchiò C; Rouzier R; Bièche I; Vincent-Salomon A
Mod Pathol; 2018 Jan; 31(1):68-82. PubMed ID: 28884749
[TBL] [Abstract] [Full Text] [Related]
18. A study of foxa1 expression in thyroid tumors.
Nonaka D
Hum Pathol; 2017 Jul; 65():217-224. PubMed ID: 28546130
[TBL] [Abstract] [Full Text] [Related]
19. foxa1 inhibits prostate cancer neuroendocrine differentiation.
Kim J; Jin H; Zhao JC; Yang YA; Li Y; Yang X; Dong X; Yu J
Oncogene; 2017 Jul; 36(28):4072-4080. PubMed ID: 28319070
[TBL] [Abstract] [Full Text] [Related]
20. The genetic landscape of breast carcinomas with neuroendocrine differentiation.
Marchiò C; Geyer FC; Ng CK; Piscuoglio S; De Filippo MR; Cupo M; Schultheis AM; Lim RS; Burke KA; Guerini-Rocco E; Papotti M; Norton L; Sapino A; Weigelt B; Reis-Filho JS
J Pathol; 2017 Feb; 241(3):405-419. PubMed ID: 27925203
[TBL] [Abstract] [Full Text] [Related]
[Next]
